Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04729387
What this trial is testing

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 358
Early research (Phase 1)Ended earlyNCT05065463
What this trial is testing

To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.

Who this might be right for
End Stage Renal Disease
AstraZeneca 3
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06751277
What this trial is testing

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Recurrent or Metastatic Endometrial Cancer
xiang yang 26
Not applicableNot Yet RecruitingNCT07841834
What this trial is testing

Assessment of Urinary Microplastic Concentration in Patients With Urolithiasis: A Prospective Case-Control Study

Who this might be right for
Urolithiasis
Konya City Hospital 100
Early research (Phase 1)Study completedNCT06063343
What this trial is testing

Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145

Who this might be right for
Ovarian Cancer
Novakand Pharma AB 50
Not applicableUnknownNCT01539785
What this trial is testing

Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence

Who this might be right for
First Recurrence of Ovarian Cancer
Catholic University of the Sacred Heart 158
Early research (Phase 1)Study completedNCT00911235
What this trial is testing

The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects

Who this might be right for
Overactive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary Incontinence
Pfizer 28
Very early researchLooking for participantsNCT06645808
What this trial is testing

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Who this might be right for
Solid TumorColon CarcinomaRectal Carcinoma+11 more
Var2 Pharmaceuticals 32
Large-scale testing (Phase 3)Active Not RecruitingNCT06087835
What this trial is testing

Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

Who this might be right for
Chronic Kidney Disease With High Proteinuria
AstraZeneca 1,835
Not applicableUnknownNCT03025919
What this trial is testing

Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)

Who this might be right for
Type II Diabetes Mellitus
Zhongda Hospital 20,000
Not applicableUnknownNCT04663412
What this trial is testing

Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer

Who this might be right for
Vulvar Cancer
Azienda Ospedaliera per l'Emergenza Canizzaro 2
Not applicableStudy completedNCT01353417
What this trial is testing

Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection

Who this might be right for
Chronic Kidney Insufficiency
Sandoz 102
Testing effectiveness (Phase 2)Study completedNCT04047017
What this trial is testing

Camrelizumab Combined With Apatinib for Recurrent Resistant GTN

Who this might be right for
Gestational Trophoblastic Disease
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00244452
What this trial is testing

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

Who this might be right for
Endometriosis
Solvay Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT05753826
What this trial is testing

Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.

Who this might be right for
Ovarian NeoplasmsOvarian Diseases
Fujian Cancer Hospital 37
Not applicableStudy completedNCT00733603
What this trial is testing

Physical Therapy in Women With Interstitial Cystitis

Who this might be right for
Interstitial CystitisPainful Bladder Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 81
Early research (Phase 1)Temporarily pausedNCT04711161
What this trial is testing

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

Who this might be right for
Ovarian Tumors
Green3Bio, Inc. 73
Early research (Phase 1)Study completedNCT02526979
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)

Who this might be right for
Overactive BladderNeurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 9
Next Page